Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AGTK $CANA $MJNE $MYHI - #Rival420 (src: fortune420.com/rival420/) Candle Glance: http://stockcharts.com/freecharts/candleglance.html?AGTK,CANA,MJNE,MYHI|B|0
The #Hemp #coin (THC) - http://www.fortune420.com/crypto420/
$NEWC Weekly - New Colombia Resources is #focused on the acquisition and development of high-quality metallurgical coal properties and other available resources in the Republic of Colombia. They own 100% of La Tabaquera metallurgical coal mine in Colombia with an estimated 15-17 million tonnes of reserves. New Colombia Resources also holds a significant position in Sannabis which legally produces medical marijuana products in Colombia
#Pot #Coin (POT) - http://www.fortune420.com/crypto420/
$NEWC Daily - New #Colombia Resources is focused on the acquisition and development of high-quality metallurgical coal properties and other available resources in the Republic of Colombia. They own 100% of La Tabaquera metallurgical coal mine in Colombia with an estimated 15-17 million tonnes of reserves. New Colombia Resources also holds a significant position in Sannabis which legally produces medical marijuana products in Colombia
#CannaCoin (CNN) - http://www.fortune420.com/crypto420/
$AGTK Daily - Agritek Holdings, Inc. provides #Innovative patient solutions and is a leader in #compassionate care technology for the #Medical #marijuana industry. Through their wholly owned subsidiary Agritek Venture Holdings, Inc. they provide real estate management and health and wellness product lines including beverages, #vaporizers and accessories. Agritek is a fully reporting company under the OTCQB and does not directly grow, harvest, distribute, or sell cannabis.
#Cannabis #Coin (CANN) http://www.fortune420.com/crypto420/
$ACAN $AMMJ $BTFL $STWC - #Rival420 (src: fortune420.com/rival420/) CandleGlance: http://stockcharts.com/freecharts/candleglance.html?ACAN,AMMJ,BTFL,STWC|B|0
Legalization On The Ballot: Live Marijuana Election Results - https://www.marijuanamoment.net/legalization-on-the-ballot-live-marijuana-election-results/
MedMen Corrects statement about acquiring cannabis dispensary from Berkeley Patients Group - https://mjbizdaily.com/medmen-corrects-statement-about-acquiring-cannabis-dispensary-from-berkeley-patients-group/
MedMen Corrects statement about acquiring cannabis dispensary from Berkeley Patients Group - https://mjbizdaily.com/medmen-corrects-statement-about-acquiring-cannabis-dispensary-from-berkeley-patients-group/
$GWPH Weekly - GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex(R), which is approved for the treatment of spasticity due to multiple sclerosis in 27 countries outside the United States. Sativex is also in Phase 3 clinical development as a potential treatment of pain associated with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW is also advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex(R), which is in Phase 2/3 clinical development for the treatment of Dravet syndrome and which is also expected to enter Phase 3 clinical trials in the treatment of Lennox-Gastaut syndrome. GW has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 clinical development for glioma, ulcerative colitis, type 2 diabetes, and schizophrenia.
$GWPH Daily - GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex(R), which is approved for the treatment of spasticity due to multiple sclerosis in 27 countries outside the United States. Sativex is also in Phase 3 clinical development as a potential treatment of pain associated with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW is also advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex(R), which is in Phase 2/3 clinical development for the treatment of Dravet syndrome and which is also expected to enter Phase 3 clinical trials in the treatment of Lennox-Gastaut syndrome. GW has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 clinical development for glioma, ulcerative colitis, type 2 diabetes, and schizophrenia.
$ATTBF Weekly - Abattis #Bioceuticals Corp. is Canadian based biotech company focused on the rapidly developing medical #marijuana industry in the United States and Canada. The company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis has multiple subsidiaries and partners. Their subsidiaries include North American BioExtracts, Biocell Labs, Northern Vine Canada, Ijuana Cannabis, and Biocube Green Grown Systems. The company’s partners include Experion Biotechnologies, Instant Payment Systems and Phytalab. Abattis trades on the Canadian stock exchange under the symbol, ATT. The company trades on the United States OTCQX exchange under the symbol, ATTBF.
$ATTBF Weekly - Abattis Bioceuticals Corp. is #Canadian based biotech company focused on the rapidly developing medical #marijuana industry in the United States and Canada. The company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. Abattis has multiple subsidiaries and partners. Their subsidiaries include North American BioExtracts, Biocell Labs, Northern Vine Canada, Ijuana Cannabis, and Biocube Green Grown Systems. The company’s partners include Experion Biotechnologies, Instant Payment Systems and Phytalab. Abattis trades on the Canadian stock exchange under the symbol, ATT. The company trades on the United States OTCQX exchange under the symbol, ATTBF.
$BLOZF Weekly - Cannabix Technologies Inc. is Canadian based #technology company focused on developing a Cannabix Marijuana Breathalyzer (patent pending). The company’s product is based on breath testing technology and is currently in the prototype stage. Cannabix is working to advance the product to a Beta prototype stage and the current Alpha prototype is not intended for third party testing. The company trades on the Canadian stock exchange under the symbol, BLO, as well as the United States OTC exchange under the symbol, BLOZF.
$BLOZF Daily - Cannabix Technologies Inc. is #Canadian based technology company focused on developing a Cannabix #Marijuana Breathalyzer (patent pending). The company’s product is based on breath testing technology and is currently in the prototype stage. Cannabix is working to advance the product to a Beta prototype stage and the current Alpha prototype is not intended for third party testing. The company trades on the Canadian stock exchange under the symbol, BLO, as well as the United States OTC exchange under the symbol, BLOZF.
$AMMJ Weekly - American #Cannabis Company Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. The company operates two vertically integrated businesses: American Cannabis Consulting and The Trade Winds, a group purchasing organization. The company utilizes these distinct businesses to provide industry specific advisory and consulting services, to develop and manufacture cultivation products and facilities, and to manage a strategic partnership that supplies ancillary products.
$AMMJ Daily - #American Cannabis Company Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. The company operates two vertically integrated businesses: American Cannabis Consulting and The Trade Winds, a group purchasing organization. The company utilizes these distinct businesses to provide industry specific advisory and consulting services, to develop and manufacture cultivation products and facilities, and to manage a strategic partnership that supplies ancillary products.
$CNAB Weekly - United Cannabis #Corporation is a developmental industry focused on the bio cannabinoid technologies industry. The company was founded to advance the use of cannabinoids in medicine through research, product development and education. United Cannabis Corporation is dedicated to improving the lives of patients through the creation of products using the highest quality genetics, purest extractions and most effective protocols possible. The company's A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provides a comprehensive solution designed to enable physicians and patients to design, implement and monitor effective therapy protocols.
$CNAB Daily - United #Cannabis Corporation is a developmental industry focused on the bio cannabinoid technologies industry. The company was founded to advance the use of cannabinoids in medicine through research, product development and education. United #Cannabis Corporation is dedicated to improving the lives of patients through the creation of products using the highest quality genetics, purest extractions and most effective protocols possible. The company's A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provides a comprehensive solution designed to enable physicians and patients to design, implement and monitor effective therapy protocols.
$CHUM Weekly - Chuma Holdings, Inc. provides turnkey #financing and support solutions to the legal cannabis industry in California. The company provides seed to sale business services, including funding and financing solutions; compliance consulting solutions; retail, collective, and dispensary solutions; banking and payment processing solutions; multichannel supply chain solutions; branding, marketing, and sales solutions; research and development solutions; consumer product solutions; and commercial production and equipment build out solutions. The company is comprised of the following subsidiaries: 1849 Holdings and Cal-Westridge Corporation. The company was formerly known as Cannamed Corporation and changed its name to Chuma Holdings, Inc. in August 2014.
$CHUM Daily - Chuma Holdings, Inc. provides #turnkey financing and support solutions to the legal cannabis industry in California. The company provides seed to sale business services, including funding and financing solutions; compliance consulting solutions; retail, collective, and dispensary solutions; banking and payment processing solutions; multichannel supply chain solutions; branding, marketing, and sales solutions; research and development solutions; consumer product solutions; and commercial production and equipment build out solutions. The company is comprised of the following subsidiaries: 1849 Holdings and Cal-Westridge Corporation. The company was formerly known as Cannamed Corporation and changed its name to Chuma Holdings, Inc. in August 2014.
$CGRW Weekly - Canna #Grow Holdings, Inc. is a developmental company that trades on the OTC-Pink Sheets and provides solutions to the #cannabis industry in Colorado. The company operates as a lessor, liaison, and consultant to licensed growers in the medical/recreational cannabis industry, as well as provides them with growing facilities. They do not grow, harvest, distribute or sell marijuana.
$CGRW Daily - #Canna Grow Holdings, Inc. is a developmental company that trades on the OTC-Pink Sheets and provides solutions to the #cannabis industry in Colorado. The company operates as a lessor, liaison, and consultant to licensed growers in the medical/recreational cannabis industry, as well as provides them with growing facilities. They do not grow, harvest, distribute or sell marijuana.
$CARA Weekly - Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase II clinical trials for the treatment acute postoperative pain in adult patients. The company is also developing Oral CR845 that has completed Phase I clinical trial for the treatment of moderate-to-severe acute and chronic pain; and CR701, which the company’s most advanced cannabinoid formula, is in preclinical trial for treating neuropathic and inflammatory pain. Cara Therapeutics, Inc. was founded in 2004 and is based in Shelton, Connecticut.
$ARNA Weekly - Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. One of the products under development is APD371, an agonist of the cannabinoid receptor 2 that is in Phase I single-ascending dose trial for the treatment of pain. The company also manufactures drug products under a manufacturing services agreement for Siegfried AG.
$ARNA Daily - Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. One of the products under development is APD371, an agonist of the cannabinoid receptor 2 that is in Phase I single-ascending dose trial for the treatment of pain. The company also manufactures drug products under a manufacturing services agreement for Siegfried AG.
$USMJ Daily - North #American Cannabis Holdings, Inc. entered the cannabis sector in 2013 through its American Seed & Oil Company subsidiary which was founded to explore a variety of high growth potential business opportunities. The company will develop current and new pilot initiatives through American #Seed & Oil Company. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers.
$MCIG Weekly - mCig, Inc. is a development company that is focused on two emerging industries: 1) the legal marijuana industry, and 2) the vaporizer and e-cigarette industry. The company is comprised of the following subsidiaries: CannaProTech LLC, Vapolution, Inc., and mCig CBD Technologies, LLC. mCig recently spun off one its VitaCig subsidiary in the form of a stock dividend to shareholders.
$MCIG Daily - mCig, Inc. is a development company that is focused on two emerging industries: 1) the legal marijuana industry, and 2) the vaporizer and e-cigarette industry. The company is comprised of the following subsidiaries: CannaProTech LLC, Vapolution, Inc., and mCig CBD Technologies, LLC. mCig recently spun off one its VitaCig subsidiary in the form of a stock dividend to shareholders.
$EAPH Weekly - Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system. The company has the exclusive option to purchase up to 49% in a medical marijuana grow-op business/facility which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.
$EAPH Daily - Easton Pharmaceuticals is a specialty #pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system. The company has the exclusive option to purchase up to 49% in a medical marijuana grow-op business/facility which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.
$TRTC Weekly - Terra Tech Corp is holding company focused on the cannabis industry. One of the company's main subsidiaries, GrowOp Technology, specializes in controlled agricultural technologies. They integrate breed hydroponic equipment with technology to create solutions for the cultivation of indoor agriculture. In April 2013, Terra Tech acquired Edible Garden and their line of locally grown hydroponic produce. In April 2014, the company formed MediPharm to focus on the Nevada cannabis market. In December 2014, they introduced a new brand of locally-produced cannabis called IVXX. IVXX is a wholly-owned subsidiary of Terra Tech.
$TRTC Daily - Terra Tech Corp is holding company focused on the #cannabis industry. One of the company's main subsidiaries, GrowOp Technology, specializes in controlled agricultural technologies. They integrate breed hydroponic equipment with technology to create solutions for the cultivation of indoor agriculture. In April 2013, Terra Tech acquired Edible Garden and their line of locally grown hydroponic produce. In April 2014, the company formed MediPharm to focus on the Nevada cannabis market. In December 2014, they introduced a new brand of locally-produced cannabis called IVXX. IVXX is a wholly-owned subsidiary of Terra Tech.
$CBDS Weekly - Cannabis #Sativa, Inc. is engaged through its recently acquired subsidiary, Kush, in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The company also offers the Skin Garden line of cosmetic products through its subsidiary, Wild Earth Naturals.
$CBDS Daily - #Cannabis Sativa, Inc. is engaged through its recently acquired subsidiary, Kush, in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The company also offers the Skin Garden line of cosmetic products through its subsidiary, Wild Earth Naturals.
$CANV Weekly - CannaVest Corp. is a developmental company focused on the procurement and wholesale of cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which the company refines into its own PlusCBD Oil brand. CannaVest resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. CannaVest Corp.'s subsidiaries include: US Hemp Oil, LLC and CannaVest Laboratories, LLC.